CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ENTXEntera Bio Ltd.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $2.91 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CountryUSA
RECENT INSIDER TRADES
  • 2026-08-07 · Taitel Haya (Director) · OTHER
  • 2026-08-07 · Malca Yonatan (Director) · OTHER
  • 2026-08-07 · Germano Geno J (Director) · OTHER
  • 2026-08-07 · Ellis Sean (Director) · OTHER
  • 2026-07-16 · Toledano Miranda Jayne (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders28
Shares held10,733,556
Value$18.78M
Percent of shares outstanding6.20%
As of quarter end2026-06-30
RECENT NEWS
  • Entera Bio to present EB613 Phase 3 study design at ASBMR meeting
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS